Target intelligence / Profile preview

GP6 antisense RNA 1 (GP6-AS1)

Target: GP6-AS1
Molecular classification: Long non-coding RNA (lncRNA)

Overview

GP6 antisense RNA 1 (GP6-AS1) is a long non-coding RNA annotated in the human genome but lacks any currently described function, role in disease, or therapeutic relevance. It is defined by its antisense orientation relative to the GP6 gene (which encodes Glycoprotein VI, a collagen receptor involved in platelet activation), but there are no data supporting functional significance or clinical relevance for GP6-AS1 at this time.

Mechanism of action

Not applicable (no drugs known to target this lncRNA)

Biological functions

Not clearly defined; no direct experimental evidence or characterized roles in human disease, physiology, or pathways as of current information

Disease associations

No robust evidence for association with disease, therapeutic development, or biomarker use

Beyond the preview

Go deeper on GP6 antisense RNA 1 (GP6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GP6 antisense RNA 1 (GP6-AS1).

Explore the full profile